Protein kinase A phosphorylates NCoR to enhance its nuclear translocation and repressive function in human prostate

Hyo-Kyoung Choi1, Jung-Yoon Yoo, Mi-Hyeon Jeong

  • 1Department of Biochemistry and Molecular Biology, Brain Korea 21 Project for Medical Sciences Korea, Yonsei University College of Medicine, Shinchon-dong, Seodaemun-gu, Seoul, South Korea. choikc75@amc.seoul.kr

Insights

Protein kinase A (PKA) enhances nuclear receptor corepressor (NCoR) function by phosphorylating its repression domain. This PKA-mediated phosphorylation increases NCoR

Area of Science:

  • Molecular Biology
  • Cellular Signaling
  • Cancer Research

Background:

  • Protein kinase A (PKA) is a key enzyme regulating diverse cellular processes through protein phosphorylation.
  • Nuclear receptor corepressor (NCoR) plays a crucial role in gene transcription repression.
  • Dysregulation of transcriptional regulation is implicated in various diseases, including prostate cancer.

Purpose of the Study:

  • To investigate the specific interaction between PKA and NCoR.
  • To elucidate the functional consequences of PKA-mediated NCoR phosphorylation.
  • To understand the role of this regulatory mechanism in prostate cancer.

Main Methods:

  • Phosphorylation assays to identify PKA substrates.
  • Site-directed mutagenesis to pinpoint critical phosphorylation sites.
  • Reporter assays and Western blotting to assess NCoR nuclear translocation and transcriptional activity.

Main Results:

  • PKA specifically phosphorylates the repression domain 1 (RD1) of NCoR.
  • Serine-70 on NCoR is identified as the critical residue for PKA-dependent phosphorylation.
  • PKA activation enhances NCoR nuclear translocation, repressive activity, and androgen receptor (AR)-mediated transcription antagonism.

Conclusions:

  • PKA positively modulates NCoR function through phosphorylation of Serine-70.
  • This regulatory pathway enhances NCoR's role in transcriptional repression.
  • The PKA-NCoR axis represents a potential therapeutic target in prostate cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...